This Article Full Text Full Text (PDF) All Versions of this Article: 38/2/411    most recent 01.STR.0000254500.27412.acv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khan, U. Articles by Markus, H. S. Search for Related Content PubMed PubMed Citation Articles by Khan, U. Articles by Markus, H. S. Related Collections Acute Cerebral Infarction Cerebral Lacunes Endothelium/vascular type/nitric oxide Related Article

(Stroke. 2007;38:411.)
© 2007 American Heart Association, Inc.

Research Reports

Asymmetric Dimethylarginine in Cerebral Small Vessel Disease

Usman Khan, MRCP; Ahamad Hassan, MRCP; Patrick Vallance, FRCP Hugh S. Markus, FRCP

From Centre for Clinical Neuroscience, St George’s University of London, London, UK.

Correspondence to Professor Hugh Markus, Centre for Clinical Neuroscience, St George’s University of London, Cranmer Terrace, London SW17 ORE, UK. E-mail hmarkus{at}sgul.ac.uk

Background and Purpose— Endothelial dysfunction may play a causal role in cerebral small vessel disease (SVD). Asymmetric dimethylarginine (ADMA), a circulating endogenous inhibitor of nitric oxide, has been implicated in endothelial dysfunction, particularly in hyperhomocystinemia, a known risk factor for SVD. We determined if ADMA was elevated in SVD, correlated with disease severity, and interacted with homocysteine.

Methods— ADMA and homocysteine levels were determined in 47 consecutive symptomatic SVD patients and 38 controls. SVD was graded by leukoariosis severity and number of lacunar infarcts.

Results— Mean (and SD) ADMA was higher in SVD patients compared with controls (0.814 [0.145] versus 0.747 [0.184] µmol/L; P=0.014) after controlling for age, gender, vascular risk factors, and creatinine clearance. Additionally controlling for homocysteine had only a small effect on this relationship (P=0.055). Mean homocysteine was higher in SVD cases compared with controls (15.14 [5.59] versus 12.49 [4.15] µmol/L; P=0.035). Leukoariosis grade correlated positively with ADMA (P=0.026) and homocysteine (P=0.003). Lacunar grade correlated with homocysteine (P=0.017), but not ADMA.

Conclusions— ADMA is independently associated with SVD and correlates with leukoariosis severity.

Key Words: ADMA • endothelial dysfunction • homocysteine • lacunar • leukoaraiosis • stroke

Related Article:

The Thr715Pro Polymorphism of the P-Selectin Gene Is Not Associated With Ischemic Stroke Risk

Julia Ferrari, Sandra Rieger, Georg Endler, Stefan Greisenegger, Marion Funk, Thomas Scholze, Wilfried Lang, Wolfgang Lalouschek, and Christine Mannhalter
Stroke 2007 38: 395-397. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				P. B. Gorelick and J. V. Bowler Advances in Vascular Cognitive Impairment 2007 Stroke, February 1, 2008; 39(2): 279 - 282. [Full Text] [PDF]

				H. Dayoub, R. N. Rodionov, C. Lynch, J. P. Cooke, E. Arning, T. Bottiglieri, S. R. Lentz, and F. M. Faraci Overexpression of Dimethylarginine Dimethylaminohydrolase Inhibits Asymmetric Dimethylarginine-Induced Endothelial Dysfunction in the Cerebral Circulation Stroke, January 1, 2008; 39(1): 180 - 184. [Abstract] [Full Text] [PDF]

				H. S. Markus Genes, endothelial function and cerebral small vessel disease in man Exp Physiol, January 1, 2008; 93(1): 121 - 127. [Abstract] [Full Text] [PDF]

				K. Tsuda Asymmetric Dimethylarginine and Hypertension in Cerebral Small Vessel Disease Stroke, July 1, 2007; 38(7): e48 - e48. [Full Text] [PDF]

				U. Khan and H. S. Markus Response to Letter by Tsuda Stroke, July 1, 2007; 38(7): e49 - e49. [Full Text] [PDF]